This OncoBlast activity uses clinical cases to explore new standards in treating gastroesophageal, colorectal, biliary, and neuroendocrine cancers. Learners will apply recent trial data to make evidence-based decisions in both curative and metastatic settings.
Course Accreditations
Course Summary
Events Starts | Events Ends |
---|---|
1/1/2025 | 12/31/2025 |
Faculty
Ronan Hsieh (MD)
As a faculty at the University of Washington Fred Hutchinson Cancer Center, I lead many clinical and translational studies in the field of gastrointestinal oncology. I focus my research on drug development using novel trial design and cancer models such as tissue slice culture and organoids, which I collaborate with translational scientists at Fred Hutch. Fun facts - I grew up in Taiwan, so you can hear me promoting bubble tea as the best beverage in the world all the time. I like hiking and cycling, and naturally I love Seattle as my new home town in the U.S.
Disclosure
Financial relationships Yes, I have had a financial relationship with an ineligible company within the past 24 months. Financial relationships: Attribution: Self Type of financial relationship: Financial Support Ineligible company: Curio Science Topic: Honorarium Attribution: Self Type of financial relationship: Professional Services Ineligible company: Bristol Myers Squibb Topic: Advisory Board Attribution: Self Type of financial relationship: Professional Services Ineligible company: Bayer Topic: Research Support Attribution: Self Type of financial relationship: Professional Services Ineligible company: Janssen Topic: Research Support Attribution: Self Type of financial relationship: Travel Ineligible company: Medscape Attribution: Self Type of financial relationship: Travel Ineligible company: Merck
- Medical oncologists
- Radiation oncologists
- Surgical oncologists
- Hematology/Oncology Fellows
Target Audience
- Select appropriate perioperative and systemic therapies for GI cancers based on latest evidence.
- Integrate biomarker testing results to guide treatment decisions across GI malignancies.
- Apply emerging standards for managing NETs and biliary cancers.
Learning Objectives
Upon successful completion of this educational activity, participants will be able to: